310 related articles for article (PubMed ID: 35401558)
1. Protein Disulfide-Isomerase A3 Is a Robust Prognostic Biomarker for Cancers and Predicts the Immunotherapy Response Effectively.
Tu Z; Ouyang Q; Long X; Wu L; Li J; Zhu X; Huang K
Front Immunol; 2022; 13():837512. PubMed ID: 35401558
[TBL] [Abstract][Full Text] [Related]
2. Sperm Autoantigenic Protein 17 Predicts the Prognosis and the Immunotherapy Response of Cancers: A Pan-Cancer Analysis.
Tu Z; Peng J; Long X; Li J; Wu L; Huang K; Zhu X
Front Immunol; 2022; 13():844736. PubMed ID: 35592314
[TBL] [Abstract][Full Text] [Related]
3. Pan-Cancer Analysis of PDIA3: Identifying It as a Potential Biomarker for Tumor Prognosis and Immunotherapy.
Zhang J; Wang K; Hainisayimu T; Li H
Oxid Med Cell Longev; 2022; 2022():9614819. PubMed ID: 36046686
[TBL] [Abstract][Full Text] [Related]
4. The cell senescence regulator p16 is a promising cancer prognostic and immune check-point inhibitor (ICI) therapy biomarker.
Tu Z; Wang X; Cai H; Sheng Y; Wu L; Huang K; Zhu X
Aging (Albany NY); 2023 Mar; 15(6):2136-2157. PubMed ID: 36961395
[TBL] [Abstract][Full Text] [Related]
5. Predictive role of E2F6 in cancer prognosis and responses of immunotherapy.
Gong C; Tu Z; Long X; Liu X; Liu F; Liu J; Zhu X; Li J; Huang K
Int Immunopharmacol; 2024 Jan; 127():111302. PubMed ID: 38071912
[TBL] [Abstract][Full Text] [Related]
6. Expression and Prognostic Significance of PDIA3 in Cervical Cancer.
Zhang J; Li H; Li H; Lin D; Wang X; Wang K
Int J Genomics; 2022; 2022():4382645. PubMed ID: 36406049
[TBL] [Abstract][Full Text] [Related]
7. PDIA3 correlates with clinical malignant features and immune signature in human gliomas.
Zhang H; Zhou Y; Cheng Q; Dai Z; Wang Z; Liu F; Fan F; Cui B; Cao H
Aging (Albany NY); 2020 Aug; 12(15):15392-15413. PubMed ID: 32687065
[TBL] [Abstract][Full Text] [Related]
8. PDIA3 Expression in Glioblastoma Modulates Macrophage/Microglia Pro-Tumor Activation.
Chiavari M; Ciotti GMP; Canonico F; Altieri F; Lacal PM; Graziani G; Navarra P; Lisi L
Int J Mol Sci; 2020 Nov; 21(21):. PubMed ID: 33153019
[TBL] [Abstract][Full Text] [Related]
9. Expression of protein disulfide isomerase A3 and its clinicopathological association in gastric cancer.
Shimoda T; Wada R; Kure S; Ishino K; Kudo M; Ohashi R; Fujita I; Uchida E; Yoshida H; Naito Z
Oncol Rep; 2019 Apr; 41(4):2265-2272. PubMed ID: 30720117
[TBL] [Abstract][Full Text] [Related]
10. Comprehensively prognostic and immunological analysis of snail family transcriptional repressor 2 in pan-cancer and identification in pancreatic carcinoma.
Zhang D; Jiang Z; Hu J; Sun X; Zheng Y; Shen Y
Front Immunol; 2023; 14():1117585. PubMed ID: 37251370
[TBL] [Abstract][Full Text] [Related]
11. P4HB and PDIA3 are associated with tumor progression and therapeutic outcome of diffuse gliomas.
Zou H; Wen C; Peng Z; Shao YΥ; Hu L; Li S; Li C; Zhou HH
Oncol Rep; 2018 Feb; 39(2):501-510. PubMed ID: 29207176
[TBL] [Abstract][Full Text] [Related]
12. Correlation between low expression of protein disulfide isomerase A3 and lymph node metastasis in papillary thyroid carcinoma and poor prognosis: a clinicopathological study of 1,139 cases with long-term follow-up.
Kure S; Chiba T; Ebina A; Toda K; Jikuzono T; Motoda N; Mitani H; Sugitani I; Takeuchi K; Ohashi R
Endocr J; 2022 Mar; 69(3):273-281. PubMed ID: 34732604
[TBL] [Abstract][Full Text] [Related]
13. Downregulation of PDIA3 inhibits gastric cancer cell growth through cell cycle regulation.
Yang M; Li Q; Yang H; Li Y; Lu L; Wu X; Liu Y; Li W; Shen J; Xiao Z; Zhao Y; Du F; Chen Y; Deng S; Cho CH; Li X; Li M
Biomed Pharmacother; 2024 Apr; 173():116336. PubMed ID: 38412717
[TBL] [Abstract][Full Text] [Related]
14. Comprehensive pan-cancer analysis reveals NUSAP1 is a novel predictive biomarker for prognosis and immunotherapy response.
Zheng H; Wang M; Zhang S; Hu D; Yang Q; Chen M; Zhang X; Zhang Y; Dai J; Liou YC
Int J Biol Sci; 2023; 19(14):4689-4708. PubMed ID: 37781040
[TBL] [Abstract][Full Text] [Related]
15. PDIA5 is Correlated With Immune Infiltration and Predicts Poor Prognosis in Gliomas.
Zhang H; He J; Dai Z; Wang Z; Liang X; He F; Xia Z; Feng S; Cao H; Zhang L; Cheng Q
Front Immunol; 2021; 12():628966. PubMed ID: 33664747
[TBL] [Abstract][Full Text] [Related]
16. Comprehensive pan-cancer investigation: unraveling the oncogenic, prognostic, and immunological significance of Abelson interactor family member 3 gene in human malignancies.
Sun A; Cai F; Xiong Q; Xie T; Li X; Xie Y; Luo R; Hu W; Zhong F; Wang S
Front Mol Biosci; 2023; 10():1277830. PubMed ID: 37942289
[No Abstract] [Full Text] [Related]
17. Protein Disulfide Isomerase A2 Is Correlated with Immune Infiltrates and Is a Novel Prognostic Biomarker in Glioma Patients.
Ma ZG; Liu YX; Zou N; Huang Z; Wang M; Li T; Zhou J; Chen LG
Curr Med Sci; 2023 Dec; 43(6):1107-1115. PubMed ID: 37978154
[TBL] [Abstract][Full Text] [Related]
18. Protein disulfide isomerase A3-specific Th1 effector cells infiltrate colon cancer tissue of patients with circulating anti-protein disulfide isomerase A3 autoantibodies.
Caorsi C; Niccolai E; Capello M; Vallone R; Chattaragada MS; Alushi B; Castiglione A; Ciccone G; Mautino A; Cassoni P; De Monte L; Álvarez-Fernández SM; Amedei A; Alessio M; Novelli F
Transl Res; 2016 May; 171():17-28.e1-2. PubMed ID: 26772958
[TBL] [Abstract][Full Text] [Related]
19. The role of PDIA3 in oral squamous cell carcinoma and its value as A diagnostic and prognostic biomarker.
Wang L; Wang X; Zhang J; Duan J; Tang C; Zhang L; Zeng H; Li H; Li Y; Zhou Y
Heliyon; 2023 Dec; 9(12):e22596. PubMed ID: 38213579
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-mediated high expression of PDIA3 was correlated with poor prognosis of patients with LUAD.
Gu X; Li X; Zhang X; Feng R; Zheng M; Liu L; Yang J; Sun H; Zhang Q; Bian T; Zhao H; Liu Y
Genomics; 2022 Jul; 114(4):110417. PubMed ID: 35724731
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
